United States Food and Drug Administration (USFDA) has concluded inspection at Panacea Biotec’s material wholly-owned subsidiary -- Panacea Biotec Pharma (PBPL) at Baddi, Himachal Pradesh. The said facility has been inspected between October 03, 2023 and October 12, 2023.
At the end of inspection, PBPL was issued a ‘FDA Form 483’ with nine observations which are related to improvements in existing procedures and are addressable. PBPL will respond to the USFDA within the stipulated time and work closely with USFDA to close the said observations.
Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.
